Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) closed the day trading at $46.84 up 0.32% from the previous closing price of $46.69. In other words, the price has increased by $0.32 from its previous closing price. On the day, 1.26 million shares were traded. SWTX stock price reached its highest trading level at $48.18 during the session, while it also had its lowest trading level at $45.355.
Ratios:
For a better understanding of SWTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.37 and its Current Ratio is at 6.41. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $75.
On December 01, 2022, BofA Securities started tracking the stock assigning a Buy rating and target price of $45.
H.C. Wainwright reiterated its Buy rating for the stock on January 19, 2021, while the target price for the stock was revised from $87 to $101.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 16 ’24 when Pichl Daniel sold 15,000 shares for $50.10 per share. The transaction valued at 751,550 led to the insider holds 45,212 shares of the business.
Ashar Bhavesh sold 4,834 shares of SWTX for $238,435 on Feb 05 ’24. The Chief Commercial Officer now owns 58,154 shares after completing the transaction at $49.32 per share. On Feb 02 ’24, another insider, Pichl Daniel, who serves as the Chief People Officer of the company, sold 26,181 shares for $44.32 each. As a result, the insider received 1,160,362 and left with 45,212 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SWTX now has a Market Capitalization of 3468965888 and an Enterprise Value of 2979026688. For the stock, the TTM Price-to-Sale (P/S) ratio is 634.19 while its Price-to-Book (P/B) ratio in mrq is 5.50. Its current Enterprise Value per Revenue stands at 546.911 whereas that against EBITDA is -8.727.
Stock Price History:
The Beta on a monthly basis for SWTX is 0.84, which has changed by 0.9813875 over the last 52 weeks, in comparison to a change of 0.23568535 over the same period for the S&P500. Over the past 52 weeks, SWTX has reached a high of $53.92, while it has fallen to a 52-week low of $18.00. The 50-Day Moving Average of the stock is -1.27%, while the 200-Day Moving Average is calculated to be 35.45%.
Shares Statistics:
Over the past 3-months, SWTX traded about 1.15M shares per day on average, while over the past 10 days, SWTX traded about 951090 shares per day. A total of 73.49M shares are outstanding, with a floating share count of 62.80M. Insiders hold about 14.90% of the company’s shares, while institutions hold 91.60% stake in the company. Shares short for SWTX as of 1713139200 were 10543122 with a Short Ratio of 9.19, compared to 1710460800 on 11174311. Therefore, it implies a Short% of Shares Outstanding of 10543122 and a Short% of Float of 17.24.
Earnings Estimates
The current rating of SpringWorks Therapeutics Inc (SWTX) is the result of assessments by 6.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of -$1.18 for the current quarter, with a high estimate of -$0.85 and a low estimate of -$1.35, while EPS last year was -$1.18. The consensus estimate for the next quarter is $1.77, with high estimates of $16.1 and low estimates of -$1.33.
Analysts are recommending an EPS of between -$2.96 and -$5.97 for the fiscal current year, implying an average EPS of -$4.7. EPS for the following year is -$3.49, with 5.0 analysts recommending between -$0.46 and -$4.42.
Revenue Estimates
For the next quarter, 7 analysts are estimating revenue of $19.89M. There is a high estimate of $37M for the next quarter, whereas the lowest estimate is $12M.
A total of 8 analysts have provided revenue estimates for SWTX’s current fiscal year. The highest revenue estimate was $135.2M, while the lowest revenue estimate was $54.2M, resulting in an average revenue estimate of $88.27M. In the same quarter a year ago, actual revenue was $5.45MBased on 6 analysts’ estimates, the company’s revenue will be $256.44M in the next fiscal year. The high estimate is $377.2M and the low estimate is $190.3M.
